HCG Cancer Centre Bengaluru is proud to announce the launch of the CyberKnife S7 System, a fully automated, AI-driven treatment delivery system with real-time motion adaptation, marking a significant advancement in the treatment of both cancerous and non-cancerous tumors. The system was unveiled by Dr.
Revenue for Q4 FY24 of INR 4,946 Million, a growth of 12% (y-o-y)and for FY24 of INR 19,121 Million, a growth of 13% (y-o-y)EBITDA for Q4 FY24 of INR 941 Million, a growth of 21% (y-o-y)and EBITDA for FY24 of INR 3,374 Million,
HCG Abdur Razzaque Ansari Cancer Hospital Ranchi announced the launch of Jharkhand’s most advanced Elekta Versa HD Platform, a versatile, all-in-one system that is capable of delivering a wide variety of external radiation therapy modalities for a broad spectrum of cancers. The media was briefed by
Envisioned to drive a new standard of cancer care, Triesta Sciences, a Unit of HealthCare Global Enterprises Limited (HCG Cancer Hospital) Bengaluru on the occasion of completion of comprehensive genomic profiling (CGP) of 1000+ cancer patients hosted a symposium on the therapeutic and prognostics utility
HCG EKO Cancer Centre, along with biker group, Eastern Bulls, organised a bike rally which was followed by a blood donation camp and a day-long entertainment event to brighten up the day for children affected by ThalassemiaHCG EKO Cancer Centre Kolkata recently organised an inspiring
Begins to install Da Vinci X systems in Mumbai, Kolkata & few other citiesHealthCare Global Enterprises Limited (HCG), the largest cancer care network in India, collaborates with Intuitive to augment the accessibility of new-age surgical technology and robotic-assisted surgery (RAS), across India, including non-metro
Revenue for Q2 FY22 of INR 4,200 Million, a growth of 19.3% (y-o-y) and 2.9% (q-o-q) Revenue for H1 FY23 of INR 8281 Million, a growth of 22.7% (y-o-y)EBITDA for Q2 FY23 of INR 810 Million, a growth of 28.0% (y-o-y) and 7.2% (q-o-q)EBITDA for
